Design, synthesis and antimycobacterial activity of some novel 3,5-dichloro-2-ethoxy-6-fluoropyridin-4 amine cyclocondensed dihydropyrimidines

Journal of Pharmacy Research - Tập 7 - Trang 241-245 - 2013
Karthikeyan Elumalai1,2, Mohammed Ashraf Ali3,2, Manogaran Elumalai4, Kalpana Eluri4, Sivaneswari Srinivasan1
1Department of Pharmaceutical Chemistry, Jayamukhi Institute of Pharmaceutical Sciences, Warangal 506 332, India
2New Drug Discovery Research, Department of Medicinal Chemistry, Sunrise University, Alwar, Rajasthan 301030, India
3Institute for Research in Molecular Medicine, Universiti Sains Malaysia, Minden 11800, Penang, Malaysia
4Faculty of Pharmacy, UCSI University, Malaysia

Tài liệu tham khảo

Kappe, 2000, Biologically active dihydropyrimidines of the Biginelli-type a literature survey, Eur J Med Chem, 35, 1043, 10.1016/S0223-5234(00)01189-2 Kappe, 2000, Recent advances in the Biginelli dihydropyrimidine synthesis. New tricks from an old dog, Acc Chem Res, 33, 879, 10.1021/ar000048h Bruce, 1966, vol. II Aron, 2010, The tethered Biginelli condensation in natural product synthesis, Chem Commun, 45, 253 Eynde, 2003, Insoluble versus soluble polymer-assisted synthesis: a first approach for the preparation of a Biginelli compound, Arkivoc, 4, 93, 10.3998/ark.5550190.0004.408 Biginelli, 1893, Aldehyde–urea derivatives of aceto-and oxaloacetic acids, Gazz Chim Ital, 23, 360 Singh, 2011, Facile transformation of Biginelli pyrimidin-2(1H)-ones to pyrimidines. In vitro evaluation as inhibitors of Mycobacterium tuberculosis and modulators of cytostatic activity, Bioorg Med Chem, 46, 2290 Desai, 2001, Synthesis and QSAR studies of 4-substituted phenyl-2,6-dimethyl-3,5-bis-n-(substituted phenyl) carbamoyl-1,4-dihydropyridines as potential antitubercular agents, Bioorg Med Chem, 9, 1993, 10.1016/S0968-0896(01)00141-9 Prashantha Kumar, 2008, CoMFA study, syntheses, antitubercular and anticancer activity of some novel 1,4-dihydropyridines, Drug Des Discov, 5, 7, 10.2174/157018008783406688 Gillespie, 2008, Antagonists of the human adenosine A2A receptor. Part 3: design and synthesis of pyrazolo[3,4-d]pyrimidines, pyrrolo[2,3 d]pyrimidines and 6-arylpurines, Bioorg Med Chem, 18, 2924, 10.1016/j.bmcl.2008.03.072 Orjales, 2008, Novel 2-(4-methylsulfonylphenyl)pyrimidine derivatives as highly potent and specific COX-2 inhibitors, Bioorg Med Chem, 16, 2183, 10.1016/j.bmc.2007.11.079 Falcao, 2006, Synthesis and antiinflammatory activity of 4-amino-2-aryl-5-cyano-6-{3- and 4-(N-phthalimidophenyl)} pyrimidines, Eur J Med Chem, 41, 276, 10.1016/j.ejmech.2005.09.009 Gangjee, 2010, Design, synthesis and evaluation of 2-amino-4-m-bromoanilino-6-arylmethyl-7 H-pyrrolo[2,3 d]pyrimidines as tyrosine kinase inhibitors and antiangiogenic agents, Bioorg Med Chem, 18, 5261, 10.1016/j.bmc.2010.05.049 Parveen, 2010, Synthesis, characterization and biological evaluation of novel 6-ferrocenyl-4-aryl-2-substituted pyrimidine derivatives, Eur J Med Chem, 45, 3497, 10.1016/j.ejmech.2010.04.023 Ibrahim, 2005, Design, synthesis, and biological evaluation of novel pyrimidine derivatives as CDK2 inhibitors, Bioorg Med Chem, 45, 1158 Tangeda, 2010, Synthesis of new pyrrolo[2,3-d]pyrimidine derivatives and evaluation of their activities against human colon cancer cell lines, Eur J Med Chem, 45, 1453, 10.1016/j.ejmech.2009.12.050 Biava, 2010, Identification of a novel pyrole derivative endowed with antimycobacterial activity and protection index comparable to that of the current antitubercular drugs streptomycin and rifampicin, Bioorg Med Chem, 18, 8076, 10.1016/j.bmc.2010.09.006